MRNA Shares Outstanding
Total shares outstanding each quarter, showing dilution from issuance or reduction from buybacks.
Shares Outstanding
Latest: 399M (2026Q2)
| Period | Value |
|---|---|
| 2023Q1 | 405M |
| 2023Q2 | 381M |
| 2023Q3 | 381M |
| 2023Q4 | 381M |
| 2024Q1 | 382M |
| 2024Q2 | 384M |
| 2024Q3 | 399M |
| 2024Q4 | 385M |
| 2025Q1 | 386M |
| 2025Q2 | 388M |
| 2025Q3 | 390M |
| 2025Q4 | 391M |
| 2026Q1 | 395M |
| 2026Q2 | 399M |
* In some reporting periods, diluted weighted-average shares are used instead of period-end shares outstanding. Please verify individual figures against the company's SEC filings.
Other MRNA Charts
More quarter-by-quarter fundamentals for Moderna, Inc.
1 / 9
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
Cumulative FCF
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Shares Outstanding
Shares Outstanding
Shares Outstanding
Latest Shares Outstanding: 399M (2026Q2); +2.9% YoY; -0.4% CAGR (3.25y).
Across the 14 quarters from 2023Q1 to 2026Q2, Shares Outstanding ranged from 381M in 2023Q2 to 405M in 2023Q1.